326 related articles for article (PubMed ID: 23692855)
1. Gain-of-function Lyn induces anemia: appropriate Lyn activity is essential for normal erythropoiesis and Epo receptor signaling.
Slavova-Azmanova NS; Kucera N; Satiaputra J; Stone L; Magno A; Maxwell MJ; Quilici C; Erber W; Klinken SP; Hibbs ML; Ingley E
Blood; 2013 Jul; 122(2):262-71. PubMed ID: 23692855
[TBL] [Abstract][Full Text] [Related]
2. Lyn kinase plays important roles in erythroid expansion, maturation and erythropoietin receptor signalling by regulating inhibitory signalling pathways that control survival.
Slavova-Azmanova NS; Kucera N; Louw A; Satiaputra J; Handoko A; Singer P; Stone L; McCarthy DJ; Klinken SP; Hibbs ML; Ingley E
Biochem J; 2014 May; 459(3):455-66. PubMed ID: 24552351
[TBL] [Abstract][Full Text] [Related]
3. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
Tong W; Zhang J; Lodish HF
Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
[TBL] [Abstract][Full Text] [Related]
4. Csk-binding protein controls red blood cell development via regulation of Lyn tyrosine kinase activity.
Plani-Lam JH; Slavova-Azmanova NS; Kucera N; Louw A; Satiaputra J; Singer P; Lam KP; Hibbs ML; Ingley E
Exp Hematol; 2017 Feb; 46():70-82.e10. PubMed ID: 27751872
[TBL] [Abstract][Full Text] [Related]
5. Liar, a novel Lyn-binding nuclear/cytoplasmic shuttling protein that influences erythropoietin-induced differentiation.
Samuels AL; Klinken SP; Ingley E
Blood; 2009 Apr; 113(16):3845-56. PubMed ID: 19064729
[TBL] [Abstract][Full Text] [Related]
6. A novel role for STAT1 in regulating murine erythropoiesis: deletion of STAT1 results in overall reduction of erythroid progenitors and alters their distribution.
Halupa A; Bailey ML; Huang K; Iscove NN; Levy DE; Barber DL
Blood; 2005 Jan; 105(2):552-61. PubMed ID: 15213094
[TBL] [Abstract][Full Text] [Related]
7. Maturation of erythroid cells and erythroleukemia development are affected by the kinase activity of Lyn.
Tilbrook PA; Palmer GA; Bittorf T; McCarthy DJ; Wright MJ; Sarna MK; Linnekin D; Cull VS; Williams JH; Ingley E; Schneider-Mergener J; Krystal G; Klinken SP
Cancer Res; 2001 Mar; 61(6):2453-8. PubMed ID: 11289114
[TBL] [Abstract][Full Text] [Related]
8. Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation.
Bouscary D; Pene F; Claessens YE; Muller O; Chrétien S; Fontenay-Roupie M; Gisselbrecht S; Mayeux P; Lacombe C
Blood; 2003 May; 101(9):3436-43. PubMed ID: 12506011
[TBL] [Abstract][Full Text] [Related]
9. CD45 tyrosine phosphatase inhibits erythroid differentiation of umbilical cord blood CD34+ cells associated with selective inactivation of Lyn.
Harashima A; Suzuki M; Okochi A; Yamamoto M; Matsuo Y; Motoda R; Yoshioka T; Orita K
Blood; 2002 Dec; 100(13):4440-5. PubMed ID: 12393728
[TBL] [Abstract][Full Text] [Related]
10. Mutation of the Lyn tyrosine kinase delays the progression of Friend virus induced erythroleukemia without affecting susceptibility.
Subramanian A; Hegde S; Correll PH; Paulson RF
Leuk Res; 2006 Sep; 30(9):1141-9. PubMed ID: 16527351
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin stimulates spleen BMP4-dependent stress erythropoiesis and partially corrects anemia in a mouse model of generalized inflammation.
Millot S; Andrieu V; Letteron P; Lyoumi S; Hurtado-Nedelec M; Karim Z; Thibaudeau O; Bennada S; Charrier JL; Lasocki S; Beaumont C
Blood; 2010 Dec; 116(26):6072-81. PubMed ID: 20844235
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin stimulates phosphorylation and activation of GATA-1 via the PI3-kinase/AKT signaling pathway.
Zhao W; Kitidis C; Fleming MD; Lodish HF; Ghaffari S
Blood; 2006 Feb; 107(3):907-15. PubMed ID: 16204311
[TBL] [Abstract][Full Text] [Related]
13. Attenuated signaling by a phosphotyrosine-null Epo receptor form in primary erythroid progenitor cells.
Li K; Menon MP; Karur VG; Hegde S; Wojchowski DM
Blood; 2003 Nov; 102(9):3147-53. PubMed ID: 12869513
[TBL] [Abstract][Full Text] [Related]
14. CrkL is recruited through its SH2 domain to the erythropoietin receptor and plays a role in Lyn-mediated receptor signaling.
Arai A; Kanda E; Nosaka Y; Miyasaka N; Miura O
J Biol Chem; 2001 Aug; 276(35):33282-90. PubMed ID: 11443118
[TBL] [Abstract][Full Text] [Related]
15. JAK2 V617F stimulates proliferation of erythropoietin-dependent erythroid progenitors and delays their differentiation by activating Stat1 and other nonerythroid signaling pathways.
Shi J; Yuan B; Hu W; Lodish H
Exp Hematol; 2016 Nov; 44(11):1044-1058.e5. PubMed ID: 27473563
[TBL] [Abstract][Full Text] [Related]
16. Spry1 as a novel regulator of erythropoiesis, EPO/EPOR target, and suppressor of JAK2.
Sathyanarayana P; Dev A; Pradeep A; Ufkin M; Licht JD; Wojchowski DM
Blood; 2012 Jun; 119(23):5522-31. PubMed ID: 22508938
[TBL] [Abstract][Full Text] [Related]
17. Epo regulates erythroid proliferation and differentiation through distinct signaling pathways: implication for erythropoiesis and Friend virus-induced erythroleukemia.
Zochodne B; Truong AH; Stetler K; Higgins RR; Howard J; Dumont D; Berger SA; Ben-David Y
Oncogene; 2000 May; 19(19):2296-304. PubMed ID: 10822380
[TBL] [Abstract][Full Text] [Related]
18. Co-operative signalling mechanisms required for erythroid precursor expansion in response to erythropoietin and stem cell factor.
Arcasoy MO; Jiang X
Br J Haematol; 2005 Jul; 130(1):121-9. PubMed ID: 15982354
[TBL] [Abstract][Full Text] [Related]
19. Erythropoiesis in the absence of janus-kinase 2: BCR-ABL induces red cell formation in JAK2(-/-) hematopoietic progenitors.
Ghaffari S; Kitidis C; Fleming MD; Neubauer H; Pfeffer K; Lodish HF
Blood; 2001 Nov; 98(10):2948-57. PubMed ID: 11698276
[TBL] [Abstract][Full Text] [Related]
20. The role of tyrosine phosphorylation in proliferation and maturation of erythroid progenitor cells--signals emanating from the erythropoietin receptor.
Klingmüller U
Eur J Biochem; 1997 Nov; 249(3):637-47. PubMed ID: 9395308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
